Adis Summary of Research: Extended‑Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder Yahiya Y. Syed Adis Summary of Research 06 May 2024 Pages: 139 - 140
Determine and remove the drug trigger, usually antibiotics, that causes acute generalised exanthematous pustulosis Esther S. KimConnie Kang Drug Reactions and Interactions 28 April 2024 Pages: 141 - 144
Adjust antimicrobial agent regimens in older patients to correct for changes in pharmacokinetics and to avoid adverse events Simon Fung Drug Reactions and Interactions 28 April 2024 Pages: 145 - 150
Increasing patient safety due to an implemented ward pharmacist in an interprofessional cancer care team evaluated in a prospective, controlled intervention study Svenja DierkesAnnette FreidankRoland Radziwill Original Research Article 29 April 2024 Pages: 151 - 159
Assessment of rational antibiotic use among children being treated in primary care facilities in Punjab, Pakistan: findings and implications Zia Ul MustafaAmer Hayat KhanBrian Godman Original Research Article 28 April 2024 Pages: 160 - 171
Correction to: Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA Hannah A. Blair Correction Open access 28 April 2024 Pages: 172 - 172